Research ArticleOriginal Research

Effect of Physician Participation in a Multi-element Health Information and Data Exchange Program on Chronic Illness Medication Adherence

Samantha F. De Leon, Lucas Pauls, Vibhuti Arya, Sarah C. Shih, Jesse Singer and Jason J. Wang
The Journal of the American Board of Family Medicine November 2015, 28 (6) 742-749; DOI: https://doi.org/10.3122/jabfm.2015.06.150010

References

  1. 1.↵
    National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention. The burden of chronic diseases and their risk factors: national and state perspectives. Atlanta: CDC; 2002.
  2. 2.↵
    1. Eckel RH,
    2. Kahn R,
    3. Robertson RM,
    4. Rizza RA
    . Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Circulation 2006;113:2943–6.
    OpenUrlFREE Full Text
  3. 3.↵
    1. Mensah GA,
    2. Brown DW
    . An overview of cardiovascular disease burden in the United States. Health Aff (Millwood) 2007;26:38–48.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Cutler JA,
    2. Sorlie PD,
    3. Wolz M,
    4. Thom T,
    5. Fields LE,
    6. Roccella EJ
    . Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004. Hypertension 2008;52:818–27.
    OpenUrlCrossRef
  5. 5.↵
    1. Ostbye T,
    2. Yarnall KS,
    3. Krause KM,
    4. Pollak KI,
    5. Gradison M,
    6. Michener JL
    . Is there time for management of patients with chronic diseases in primary care? Ann Fam Med 2005;3:209–14.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Bodenheimer T,
    2. Chen E,
    3. Bennett HD
    . Confronting the growing burden of chronic disease: can the U.S. health care workforce do the job? Health Aff (Millwood) 2009;28:64–74.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Thier SL,
    2. Yu-Isenberg KS,
    3. Leas BF,
    4. et al
    . In chronic disease, nationwide data show poor adherence by patients to medication and by physicians to guidelines. Manag Care 2008;17:48–52.
    OpenUrlPubMed
  8. 8.↵
    1. Briesacher BA,
    2. Andrade SE,
    3. Fouayzi H,
    4. Chan KA
    . Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy 2008;28:437–43.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Yeaw J,
    2. Benner JS,
    3. Walt JG,
    4. Sian S,
    5. Smith DB
    . Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm 2009;15:728–40.
    OpenUrlPubMedWeb of Science
  10. 10.↵
    1. Kyanko KA,
    2. Franklin RH,
    3. Angell SY
    . Adherence to chronic disease medications among New York City Medicaid participants. J Urban Health 2013;90:323–8.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Pladevall M,
    2. Williams LK,
    3. Potts LA,
    4. Divine G,
    5. Xi H,
    6. Lafata JE
    . Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care 2004;27:2800–5.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Parris ES,
    2. Lawrence DB,
    3. Mohn LA,
    4. Long LB
    . Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia. Diabetes Care 2005;28:595–9.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Svarstad BL,
    2. Shireman TI,
    3. Sweeney JK
    . Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatr Serv 2001;52:805–11.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Lau DT,
    2. Nau DP
    . Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care 2004;27:2149–53.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Ho PM,
    2. Spertus JA,
    3. Masoudi FA,
    4. et al
    . Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006;166:1842–7.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Newby LK,
    2. LaPointe NM,
    3. Chen AY,
    4. et al
    . Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation 2006;113:203–12.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Ho PM,
    2. Rumsfeld JS,
    3. Masoudi FA,
    4. et al
    . Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006;166:1836–41.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Balkrishnan R,
    2. Rajagopalan R,
    3. Camacho FT,
    4. Huston SA,
    5. Murray FT,
    6. Anderson RT
    . Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther 2003;25:2958–71.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Sokol MC,
    2. McGuigan KA,
    3. Verbrugge RR,
    4. Epstein RS
    . Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521–30.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Roebuck MC,
    2. Liberman JN,
    3. Gemmill-Toyama M,
    4. Brennan TA
    . Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff (Millwood) 2011;30:91–9.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Friedberg MW,
    2. Lai DJ,
    3. Hussey PS,
    4. Schneider EC
    . A guide to the medical home as a practice-level intervention. Am J Manag Care 2009;15:S291–9.
    OpenUrlPubMed
  22. 22.↵
    1. Carter BL,
    2. Bosworth HB,
    3. Green BB
    . The hypertension team: the role of the pharmacist, nurse, and teamwork in hypertension therapy. J Clin Hypertens (Greenwich) 2012;14:51–65.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Kraschnewski JL,
    2. Gabbay RA
    . Role of health information technologies in the Patient-centered Medical Home. J Diabetes Sci Technol 2013;7:1376–85.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Shah NR,
    2. Hirsch AG,
    3. Zacker C,
    4. Taylor S,
    5. Wood GC,
    6. Stewart WF
    . Factors associated with first-fill adherence rates for diabetic medications: a cohort study. J Gen Intern Med 2009;24:233–7.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Hunt J,
    2. Rozenfeld Y,
    3. Shenolikar R
    . Effect of patient medication cost share on adherence and glycemic control. Manag Care 2009;18:47–53.
    OpenUrlPubMed
  26. 26.↵
    1. Gibson TB,
    2. Wang S,
    3. Kelly E,
    4. et al
    . A value-based insurance design program at a large company boosted medication adherence for employees with chronic illnesses. Health Aff (Millwood) 2011;30:109–17.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Mostashari F,
    2. Tripathi M,
    3. Kendall M
    . A tale of two large community electronic health record extension projects. Health Aff (Millwood) 2009;28:345–56.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Farley TA,
    2. Dalal MA,
    3. Mostashari F,
    4. Frieden TR
    . Deaths preventable in the U.S. by improvements in use of clinical preventive services. Am J Manag Care 2010;38:600–9.
    OpenUrl
  29. 29.↵
    Take care New York 2012: a policy for a healthier New York City, September 2009. New York: New York City Department of Health & Mental Hygiene. Available from: http://www.nyc.gov/html/doh/downloads/pdf/tcny/tcny-2012.pdf. Accessed May 5, 2015.
  30. 30.↵
    1. Ford ES,
    2. Giles WH,
    3. Dietz WH
    . Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356–9.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    Payscale, Inc. Average salary for Seiu 32BJ employees. Available from: http://www.payscale.com/research/US/Employer=Seiu_32Bj/Salary. Accessed March 3, 2015.
  32. 32.↵
    32BJ SEIU. Who we are. Available from: http://www.seiu32bj.org/who-we-are/. Accessed March 3, 2015.
  33. 33.↵
    1. Andrade SE,
    2. Kahler KH,
    3. Frech F,
    4. Chan KA
    . Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006;15:565–74, discussion 75–77.
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    1. Bender BG,
    2. Apter A,
    3. Bogen DK,
    4. et al
    . Test of an interactive voice response intervention to improve adherence to controller medications in adults with asthma. J Am Board Fam Med 2010;23:159–65.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    1. Vollmer WM,
    2. Feldstein A,
    3. Smith DH,
    4. et al
    . Use of health information technology to improve medication adherence. Am J Manag Care 2011;17:SP79–87.
    OpenUrlPubMed
  36. 36.↵
    1. Pape GA,
    2. Hunt JS,
    3. Butler KL,
    4. et al
    . Team-based care approach to cholesterol management in diabetes mellitus: two-year cluster randomized controlled trial. Arch Intern Med 2011;171:1480–6.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Allen JK,
    2. Dennison-Himmelfarb CR,
    3. Szanton SL,
    4. et al
    . Community Outreach and Cardiovascular Health (COACH) Trial: a randomized, controlled trial of nurse practitioner/community health worker cardiovascular disease risk reduction in urban community health centers. Circ Cardiovasc Qual Outcomes 2011;4:595–602.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Berdine HJ,
    2. Skomo ML
    . Development and integration of pharmacist clinical services into the patient-centered medical home. J Am Pharm Assoc 2012;52:661–7.
    OpenUrlCrossRef
  39. 39.↵
    1. Odum L,
    2. Whaley-Connell A
    . The role of team-based care involving pharmacists to improve cardiovascular and renal outcomes. Cardiorenal Med 2012;2:243–50.
    OpenUrlCrossRefPubMedWeb of Science
  40. 40.↵
    1. Wroth TH,
    2. Pathman DE
    . Primary medication adherence in a rural population: the role of the patient-physician relationship and satisfaction with care. J Am Board Fam Med 2006;19:478–86.
    OpenUrlAbstract/FREE Full Text
  41. 41.↵
    1. Munger MA,
    2. Van Tassell BW,
    3. LaFleur J
    . Medication nonadherence: an unrecognized cardiovascular risk factor. MedGenMed 2007;9:58.
    OpenUrlPubMed
  42. 42.↵
    1. Kaplan JE,
    2. Keeley RD,
    3. Engel M,
    4. Emsermann C,
    5. Brody D
    . Aspects of patient and clinician language predict adherence to antidepressant medication. J Am Board Fam Med 2013;26:409–20.
    OpenUrlAbstract/FREE Full Text
  43. 43.↵
    1. Rashid MA,
    2. Edwards D,
    3. Walter FM,
    4. Mant J
    . Medication taking in coronary artery disease: a systematic review and qualitative synthesis. Ann Fam Med 2014;12:224–32.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords